Isaka Y - Search Results

1

NEDD4-family E3 ligase dysfunction due to PKHD1/Pkhd1 defects suggests a mechanistic model for ARPKD pathobiology.

Kaimori JY, Lin CC, Outeda P, Garcia-Gonzalez MA, Menezes LF, Hartung EA, Li A, Wu G, Fujita H, Sato Y, Nakanuma Y, Yamamoto S, Ichimaru N, Takahara S, Isaka Y, Watnick T, Onuchic LF, Guay-Woodford LM, Germino GG. Kaimori JY, et al. Among authors: isaka y. Sci Rep. 2017 Aug 10;7(1):7733. doi: 10.1038/s41598-017-08284-4. Sci Rep. 2017. PMID: 28798345 Free PMC article.

2

Gene transfer into the liver by plasmid injection into the portal vein combined with electroporation.

Kobayashi S, Dono K, Tanaka T, Takahara S, Isaka Y, Imai E, Nagano H, Tomoaki K, Umeshita K, Nakamori S, Sakon M, Monden M. Kobayashi S, et al. Among authors: isaka y. J Gene Med. 2003 Mar;5(3):201-8. doi: 10.1002/jgm.329. J Gene Med. 2003. PMID: 12666186

3

Direct transfer of hepatocyte growth factor gene into kidney suppresses cyclosporin A nephrotoxicity in rats.

Yazawa K, Isaka Y, Takahara S, Imai E, Ichimaru N, Shi Y, Namba Y, Okuyama A. Yazawa K, et al. Among authors: isaka y. Nephrol Dial Transplant. 2004 Apr;19(4):812-6. doi: 10.1093/ndt/gfh064. Nephrol Dial Transplant. 2004. PMID: 15031334

4

ABO-incompatible kidney transplantation with anti-CD20 monoclonal antibodies, intravenous immunoglobulin and plasmapheresis without splenectomy: a case report.

Imamura R, Ishiguro S, Shi Y, Namba Y, Ichimaru N, Isaka Y, Takahara S, Okuyama A. Imamura R, et al. Among authors: isaka y. Xenotransplantation. 2006 Mar;13(2):133-5. doi: 10.1111/j.1399-3089.2006.00295.x. Xenotransplantation. 2006. PMID: 16623807

5

Targeting of interstitial cells using a simple gene-transfer strategy.

Fujii N, Isaka Y, Takabatake Y, Mizui M, Suzuki C, Takahara S, Ito T, Imai E. Fujii N, et al. Among authors: isaka y. Nephrol Dial Transplant. 2006 Oct;21(10):2745-53. doi: 10.1093/ndt/gfl327. Epub 2006 Jul 5. Nephrol Dial Transplant. 2006. PMID: 16822795

6

Incidence of positive C4d deposition in long-term survival cases over 10 yr after renal transplantation.

Namba Y, Oka K, Moriyama T, Kyo M, Imamura R, Shi Y, Ichimaru N, Isaka Y, Takahara S, Okuyama A. Namba Y, et al. Among authors: isaka y. Clin Transplant. 2006;20 Suppl 15:20-5. doi: 10.1111/j.1399-0012.2006.00545.x. Clin Transplant. 2006. PMID: 16848871

7

Carbamylated erythropoietin protects the kidneys from ischemia-reperfusion injury without stimulating erythropoiesis.

Imamura R, Isaka Y, Ichimaru N, Takahara S, Okuyama A. Imamura R, et al. Among authors: isaka y. Biochem Biophys Res Commun. 2007 Feb 16;353(3):786-92. doi: 10.1016/j.bbrc.2006.12.099. Epub 2006 Dec 22. Biochem Biophys Res Commun. 2007. PMID: 17196938

8

Risk factors for malignancy in Japanese renal transplant recipients.

Imao T, Ichimaru N, Takahara S, Kokado Y, Okumi M, Imamura R, Namba Y, Isaka Y, Nonomura N, Okuyama A. Imao T, et al. Among authors: isaka y. Cancer. 2007 May 15;109(10):2109-15. doi: 10.1002/cncr.22636. Cancer. 2007. PMID: 17407138 Free article.

9

Erythropoietin protects the kidneys against ischemia reperfusion injury by activating hypoxia inducible factor-1alpha.

Imamura R, Moriyama T, Isaka Y, Namba Y, Ichimaru N, Takahara S, Okuyama A. Imamura R, et al. Among authors: isaka y. Transplantation. 2007 May 27;83(10):1371-9. doi: 10.1097/01.tp.0000264200.38926.70. Transplantation. 2007. PMID: 17519789

10

Chemically modified siRNA prolonged RNA interference in renal disease.

Takabatake Y, Isaka Y, Mizui M, Kawachi H, Takahara S, Imai E. Takabatake Y, et al. Among authors: isaka y. Biochem Biophys Res Commun. 2007 Nov 16;363(2):432-7. doi: 10.1016/j.bbrc.2007.08.189. Epub 2007 Sep 11. Biochem Biophys Res Commun. 2007. PMID: 17880921

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

538 results

Search Page